Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT

Inclusion Criteria:

• Aged 20 to 75 years old.
• Subjects who need CT scan
• Subjects who are willing to participate in the study and to write the informed consent form.

Exclusion Criteria:

• Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3
• Severe disorder of thyroid gland
• homocystinuria
• pregnant or breastfeeding female subjects, or female subjects with childbearing potential who are not willing to use proper contraception methods
• Participation in another clinical trial within 30days of enrollment into this study.